MedPath

Effect of Shock Waves Therapy on Chronic Anal Fissure

Not Applicable
Conditions
Chronic Anal Fissure
Interventions
Device: shock master (shock waves device)
Registration Number
NCT04793347
Lead Sponsor
amr bayoumi salama
Brief Summary

the study conducted to assess if there is an effect of Extracorporeal Shock Wave Treatment on anal fissure

Detailed Description

Design of the study:

A prospective, randomized, blind, paired (right/left) comparison.

Materials:

Measurement tool:

* healing of anal fissure,

* Wexner Constipation Scoring System

* anal pain intensity by means of a 10-point visual analogue scale (VAS)

Therapeutic instruments:

•. shock waves

• topical application of 0.4% glyceryl trinitrate (GTN) ointment

Methods:

• Testing procedures: The assessment will be performed before commencing treatment, after 4 and 8 weeks of the treatment.

• Treatment procedures: Patients will be assigned randomly into two groups equal in number: shock waves Group: twenty patients will receive the shockwaves on perianal area of for 4 weeks (3 sessions /week). control Group: twenty patients will receive the recommended routine medical treatment include topical application of 0.4% glyceryl trinitrate (GTN) ointment only..

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • patient with chronic anal fissure
  • symptomatic for at least 6 months
  • failed conservative measures
Exclusion Criteria
  • Pregnant women,
  • cardiac patients,
  • patients with a pacemaker,
  • low molecular heparin or warfarin treatment,
  • neurological disease,

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
shock wavesshock master (shock waves device)group of patients with anal fissure will be treated with shock waves
Primary Outcome Measures
NameTimeMethod
VASup to 3 months

assessment of pain

Secondary Outcome Measures
NameTimeMethod
wexener scaleup to 3 months

assess the constipation

Trial Locations

Locations (1)

Amr

🇪🇬

Giza, Egypt

© Copyright 2025. All Rights Reserved by MedPath